Parambil announced it has raised $6 million in seed funding led by Bling Capital, with participation from NVP Capital and strategic angels across mass torts, personal injury, and legal tech. Parambil’s founders are betting on a fundamental shift in how justice is administered in America and how that shift will ultimately improve healthcare itself.
“Traditional high-volume litigation – motor vehicle accidents, slip-and-falls – will face increased margin compression due to automation,” said Sara Cordrey, CEO and co-founder. “What won’t be automated is complex litigation. Medical malpractice, birth injuries, nursing home abuse, mass torts – these require deep medical and legal nuance that general AI and algorithms cannot deliver.”
Parambil’s customer base reflects the universal challenge of medical complexity: both plaintiff firms and defense counsel face the same 60,000-page records and need the same accurate analysis. “Whether you’re evaluating a potential claim or defending against one, the challenge is identical: understanding what happened medically, why it matters legally, and what the case is worth,” Cordrey said. Plaintiff firms use Parambil to identify strong cases faster and reject weak ones earlier. Defense teams and corporations use it to assess exposure, prioritise resources, and develop defense strategies.”
“Parambil transforms hours of manual review into minutes while increasing accuracy and consistency,” said Ben Ling, Founder of Bling Capital. “That’s not incremental improvement, it’s a fundamental shift in how complex cases are analysed and resolved.”
Dan Borok, Partner at NVP Capital, added: “The legal system has never had a scalable way to handle the sheer volume and medical complexity embedded in high-stakes litigation until Parambil. As investors focused on AI for under-digitised industries, we were struck by the founding team’s rare combination of medical depth, litigation experience, and AI expertise. It’s exactly the mix required to transform how complex cases are analysed, valued, and resolved.”
Dr Jeffrey L. Horstmyer, MD, PA, angel investor and practising neurologist, said: “As both an investor and active user, Parambil is a world-class, high-trust AI platform purpose-built for complex, high-stakes litigation. The rapid acceptance we’re seeing across the legal community reinforces our conviction that Parambil is the market leader and new standard for AI medical-legal platforms.”
Parambil will use the funds to accelerate platform engineering, expand domain-specific AI workflows at the intersection of medicine and law, and scale customer success to meet growing demand.
Read full article: https://www.parambil.com/blogs/parambil-raises-6m-to-build-the-future-of-complex-litigation—and-transform-healthcare-in-the-process
